Clal Bio: Exit of NIS 88-325 million – Cadnet is sold to Novartis – the capital market
Exit to the company Clal Biotechno + 8.95% Base:188.9 opening:210 Tall:212 low:198 change:4,148,607 Page Quote News Graphs Company Profile Recommendations More articles on the subject: Cadent Thera…
